Early peanut introduction tied to big drop in childhood food allergies, CHOP study finds
A 2025 Children’s Hospital of Philadelphia study shows that introducing peanuts early in infancy is linked to a 27% drop in peanut allergies and a 38% reduction in overall food-allergy diagnoses across US pediatric practices.
Key takeaways
- Large, real‑world dataset: CHOP researchers reviewed electronic health records for more than 120,000 children across dozens of U.S. pediatric practices.
- Substantial declines: Early peanut introduction was associated with a 27% reduction in peanut-allergy diagnoses and a 38% drop in all food-allergy diagnoses.
- Supports guideline shifts: Findings reinforce changes after the 2015 LEAP trial and 2021 recommendations to introduce allergens early.
- Safety first: Whole nuts are a choking hazard; parents should consult pediatricians before introducing allergens.
What the CHOP study looked at
Researchers at Children’s Hospital of Philadelphia reviewed electronic health records for more than 120,000 children seen at dozens of pediatric practices around the country. The team compared rates of new allergy diagnoses over time as clinical guidance shifted toward early peanut introduction. CHOP describes the work in a hospital news release: CHOP news.
Main findings
27% fewer peanut allergy diagnoses and a 38% reduction in overall food-allergy diagnoses were observed in the analyzed records.
The study is observational: it shows strong associations between earlier peanut introduction and lower recorded allergy rates but cannot alone prove causation. The analysis used records through early 2019 and relies on diagnoses recorded in electronic health records, which can undercount or misclassify cases.
How this fits with past research
For years parents were advised to delay allergen introduction. That guidance changed after the 2015 LEAP trial, which found that high-risk infants who consumed peanut between about 4 and 11 months had far lower rates of peanut allergy later in childhood. Coverage of that work and its influence is summarized in reports such as Fox News report. Professional groups followed with 2021 recommendations to introduce peanuts, eggs and other common allergens as early as 4 to 6 months for most infants; the CHOP study provides real-world evidence that those guideline shifts are affecting population-level trends. See an allergy society summary at ACAAI.
Real-world impact seen in the data
The CHOP findings mirror other reports. For example, the National Peanut Board reported a 43% decline in peanut allergy rates among children under 3 since early-introduction recommendations began, and some surveillance shows eggs becoming a more commonly reported allergen than peanuts in certain samples. These trends suggest that early-introduction messaging has reached many families and clinicians.
Why early exposure appears to work
Immunologists explain that early-life exposure to food proteins in the gut helps the developing immune system learn tolerance rather than mounting an allergic response. Introducing small, age-appropriate forms of peanut at the start of solids (often around 4–6 months) and maintaining regular exposure—about twice weekly through the first year—appears most protective.
Safety and practical steps for parents
- Never give whole nuts to babies or toddlers due to choking risk. Use peanut butter thinned with water, peanut purée, or infant peanut-containing puffs when starting exposure (see guidance from ACAAI).
- High-risk infants: If a baby has severe eczema or a known egg allergy, discuss timing and possible testing with your pediatrician; earlier introduction (around 4 months) or specialist input may be advised (overview: Lurie Children’s).
- Know anaphylaxis: Although rare, severe allergic reactions require immediate epinephrine and emergency care. Parents should learn to recognize dangerous symptoms and have a plan for urgent treatment.
Study strengths and limits
Strengths include the large sample size and multisite, real-world data drawn from many practices, making the results applicable to everyday clinical care. Limitations: records used were through early 2019 (before 2021 guideline updates), the analysis depends on electronic health record diagnoses that may misclassify or miss cases, and the study is observational rather than randomized.
What pediatricians and public health officials say
Clinicians have increasingly embraced early peanut introduction as a preventive tool, and professional societies have worked to translate trial findings into clear guidance. Surveys indicate some parents remain uncertain about preparation, timing, and frequency; targeted education and clinician training can help close that gap so more infants benefit.
Implications for the United States
Public health gains: The CHOP study suggests updated guidance is translating into lower allergy rates nationally, which may reduce long-term healthcare needs and parental burden.
Parental choice and access: Clear, evidence-based recommendations help parents make safer choices; expanding access to pediatric care and community education is key.
Health equity: Efforts must reach diverse and underserved communities so benefits are widespread.
Schools and childcare: Declining peanut-allergy prevalence could prompt policy updates balancing safety and lower population risk.
Food industry: Increased early peanut consumption may spur infant-friendly products with clear labeling and safety guidance.
Notable quote
“The CHOP analysis provides strong, real-world evidence that earlier peanut introduction is associated with meaningful declines in childhood food-allergy diagnoses,” researchers say in the hospital news release.
